China Pharma Holdings (CPHI) |
|
0.4865 -0.059 (-10.73%)
|
11-27 01:18 |
|
Open: |
0.53 |
Pre. Close: |
0.545 |
|
High:
|
0.56 |
Low:
|
0.4636 |
|
Volume:
|
1,564,014 |
Market Cap:
|
21M |
|
|
|
|
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 397 full-time employees. The firm conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson) in the People's Republic of China (PRC). The company is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC. The company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. Its pharmaceutical products are sold on a prescription basis and are approved by the China Food and Drug Administration (the CFDA). The firm manufactured over 20 pharmaceutical products for various diseases and medical indications. The company offers products for Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases and Others. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.56 - 0.563 |
0.563 - 0.565 |
|
Low:
|
0.454 - 0.457 |
0.457 - 0.459 |
|
Close:
|
0.486 - 0.49 |
0.49 - 0.494 |
|
Technical analysis |
as of: 2020-11-25 4:37:09 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 0.70 One year: 0.82 |
| Support: |
Support1: 0.46 Support2: 0.37 |
| Resistance: |
Resistance1: 0.60 Resistance2: 0.70 |
| Pivot: |
0.42  |
| Moving Average: |
MA(5): 0.46 MA(20): 0.42
MA(100): 0.44 MA(250): 0.46 |
| MACD: |
MACD(12,26): 0.02 Signal(9): 0.01 |
| Stochastic oscillator: |
%K(14,3): 71.54 %D(3): 79.37 |
| RSI: |
RSI(14): 62.14 |
| 52-week: |
High: 1.40 Low: 0.22 Change(%): 111.5 |
| Average Vol(K): |
3-Month: 46100 10-Days: 68859 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.CPHI has closed below upper band by 10.9%. Bollinger Bands are 50.2% wider than normal. The large width of the bands suggest high volatility as compared to CPHI's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Wed, 25 Nov 2020
China Pharma Holdings Inc. [CPHI] gain 130.15% so far this year. What now? - The DBT News
Wed, 25 Nov 2020
Are You Looking For Active Stock? China Pharma Holdings, (CPHI) - The Union Journal
Wed, 25 Nov 2020
The Forecast Just Changed on China Pharma Holdings Inc. (AMEX:CPHI) - The Oracle Dispatch
Wed, 25 Nov 2020
Where do analysts think the China Pharma Holdings, Inc. (NYSE:CPHI) is going - Stocks Register
Fri, 13 Nov 2020
China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results - PRNewswire
Wed, 21 Oct 2020
China Pharma Holdings: 5 Things for Potential CPHI Stock Investors to Know - Investorplace.com
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Neutral |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Neutral |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Drug Manufacturers General Specialty & Generic |
| Shares Out. (M) |
44 |
| Shares Float (M) |
22 |
|
% Held by Insiders
|
49.66 |
|
% Held by Institutions
|
2.33 |
|
Shares Short (K)
|
125 |
|
Shares Short P. Month (K)
|
179 |
Stock Financials |
|
EPS
|
-0.461 |
|
EPS Est This Year
|
0.420 |
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
0.190 |
|
Profit Margin
|
-183.34 |
|
Operating Margin
|
-25.82 |
|
Return on Assets (ttm)
|
-5.3 |
|
Return on Equity (ttm)
|
-107.6 |
|
Qtrly Rev. Growth
|
46.8 |
|
Gross Profit (p.s.)
|
0.034 |
|
Sales Per Share
|
0.251 |
|
EBITDA (p.s.)
|
-0.004 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
0 |
|
Levered Free Cash Flow (M)
|
2 |
Stock Valuations |
|
PE Ratio
|
-1.06 |
|
PEG Ratio
|
|
|
Price to Book value
|
2.56 |
|
Price to Sales
|
1.93 |
|
Price to Cash Flow
|
69.42 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
